Introduction
============

Osteoarthritis (OA) is a degenerative joint disease that affects more than 27 million people in the US alone \[[@B1]\]. OA is characterized by biochemical and morphologic degradation of joint tissues (in particular, the articular hyaline cartilage). The process of cartilage loss is manifested by biochemical degeneration (proteoglycan loss, increased water content, collagen degradation, and chondrocyte response to tissue damage) as well as morphologic degeneration such as fibrillation and cartilage thinning \[[@B2],[@B3]\]. Biochemical alterations to the articular cartilage often occur prior to morphologic degeneration \[[@B4]\]; thus, evaluating the biochemical composition of cartilage may be valuable for the early detection of OA.

Magnetic resonance (MR) T~2~relaxation time is sensitive to biochemical changes that occur during cartilage degeneration, including alterations in hydration, collagen content, and tissue anisotropy \[[@B5]\]. Mean cartilage T~2~has been used to distinguish subjects with early OA from healthy subjects \[[@B6]\]. Recent studies have suggested that, in addition to mean T~2~, the spatial distribution of cartilage T~2~values may be important when examining the pathogenesis of OA \[[@B7]-[@B9]\]. Early degenerative changes of the cartilage matrix due to disease or injury are reflected by the spatial distribution of T~2~values and can be quantified by grey level co-occurrence matrix (GLCM) texture analysis \[[@B10]\]. GLCM entropy of cartilage T~2~has been found to be elevated in patients with OA as compared with controls \[[@B7],[@B9]\], demonstrating that not only mean T~2~\[[@B6]\] but also the spatial distribution of T~2~values is affected by disease.

The Osteoarthritis Initiative (OAI) is a multi-center longitudinal study aimed at assessing biomarkers in OA, including those derived from MR imaging (MRI). The OAI is a cross-sectional and longitudinal dataset that includes both MRI and radiographic images of subjects, scanned annually over 4 years. MR images that can be used to assess joint morphology and cartilage T~2~are available. This database provides a means to longitudinally evaluate MRI biomarkers, including T~2~relaxation time in the development and progression of OA, thus providing a wealth of information on OA development and progression.

While many previous studies have evaluated subjects with symptomatic and radiographic OA \[[@B11]-[@B13]\], the present study evaluates subjects at risk for developing OA (but without radiographic knee degeneration or pain within the week before MRI) as well as normal controls. This patient cohort is unique, facilitating the assessment of early biochemical changes in OA which occur prior to morphologic degeneration detected by radiography. Since early morphologic degeneration in the joint may not be detected by radiography \[[@B14],[@B15]\], this study uses MRI to assess cartilage and meniscus morphology. The MR whole-organ magnetic resonance imaging scores (WORMS) \[[@B16]\] are employed for focal knee evaluation, and MR T~2~relaxation time is used for the assessment of cartilage biochemical composition. The goals of this study were (a) to compare the prevalence of focal knee abnormalities, the mean cartilage T~2~relaxation time, and the spatial distribution of cartilage MR T~2~relaxation times between subjects with risk factors for OA and those without them; (b) to determine the relationship between MR cartilage T~2~parameters, age, and cartilage morphology as determined by WORMS; and (c) to assess the reproducibility of WORMS scoring and T~2~relaxation time measurements, including the mean and GLCM texture parameters.

Materials and methods
=====================

Subjects
--------

A subset of subjects from the incidence (n = 92) and control (n = 53) cohorts of the OAI \[[@B17]\] was selected on the basis of the inclusion criteria of this study. The incidence cohort did not have symptomatic knee OA - criteria were no \'frequent knee symptoms in the past 12 months, defined as \"pain, aching, or stiffness in or around the knee on most days\" for at least 1 month during the past 12 months, and no radiographic tibiofemoral knee OA, defined as definite tibiofemoral osteophytes (Osteoarthritis Research Society International atlas grades 1 to 3, equivalent to Kellgren-Lawrence (KL) grade of at least 2 on fixed flexion radiographs in either knee at baseline)\' \[[@B17]\] - but did have risk factors for OA, including being overweight (defined using gender- and age-specific cut-points for weight: males of greater than 92.9 kg and females of greater than 77.1 kg from the age of 45 to 69 years) or having knee injury (defined as a history of knee injury causing difficulty walking for at least 1 week), knee surgery (defined as a history of knee surgery, including meniscal and ligamentous repairs and unilateral total knee replacement for OA), family history of total knee replacement (defined as a total knee replacement for OA in a biological parent or sibling), or Heberden nodes (defined as self-report of bony enlargement of 1+ distal interphalangeal joint in both hands) \[[@B17]\]. Subjects from the control cohort had no knee symptoms or risk factors for OA. The exclusion criteria for the study included rheumatoid arthritis, bilateral total knee joint replacement, and a positive pregnancy test. The specific inclusion criteria for this study were (a) age range of 45 to 55 years, (b) body mass index (BMI) of 19 to 27 kg/m^2^, (c) Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score of 0, and (d) KL score of 0 at baseline. These parameters were chosen in order to examine a middle-aged, non-obese, and asymptomatic population without radiographic evidence of OA. The following OAI datasets were assessed in this study: baseline clinical dataset 0.2.2 and baseline imaging datasets 0.E.1 and 0.C.2. The institutional review boards at all units participating in the OAI, including the clinical centers and the OAI Coordinating Center at University of California San Francisco, have reviewed and approved the protocol and consent forms for the OAI study. All OAI study participants signed informed consent forms for participation in the study.

Knee radiographs
----------------

Bilateral standing posterior-anterior fixed flexion knee radiographs were acquired at baseline. Knees were positioned in a plexiglass frame (SynaFlexer; CCBR-Synarc, Newark, CA, USA) with 20° to 30° flexion and 10° internal rotation of the feet. In an additional reading performed for the present study, knee radiographs were graded by two radiologists (LN and WV) in consensus by using the KL scoring system \[[@B18]\]. The KL score included only the tibiofemoral joint and not the patellofemoral joint since the OAI used the posterior-anterior \'fixed flexion\' knee radiograph protocol, which is a primary protocol for tibiofemoral joint radiography.

Magnetic resonance imaging
--------------------------

MR images were obtained with four identical 3.0 Tesla scanners (Siemens Magnetom Trio, Erlangen, Germany) and quadrature transmit-receive coils (USA Instruments, Aurora, OH, USA) in Columbus, OH; Baltimore, MD; Pittsburgh, PA; and Pawtucket, RI. The following sequences were acquired and used for image analysis: sagittal two-dimensional (2D) intermediate-weighted (IW) fast spin-echo (FSE) sequence (resolution = 0.357 × 0.511 × 3.0 mm) and a coronal 2D IW FSE sequence (resolution = 0.365 × 0.456 × 3.0 mm). A sagittal 2D multi-slice multi-echo (MSME) sequence (TE~1~-TE~7~= 10, 20, 30, 40, 50, 60, 70 ms, resolution = 0.313 × 0.446 × 3.0 mm, and 0.5 mm gap) was used for T~2~measurements \[[@B19]\].

Image analysis
--------------

All images were analyzed with a Sun Workstation (Sun Microsystems, now part of Oracle Corporation, Redwood Shores, CA, USA). Knee articular cartilage was segmented manually in five compartments (patella, medial femur, medial tibia, lateral femur, and lateral tibia) as previously reported \[[@B20],[@B21]\]. An IDL (Interactive Data Language, Research Systems, Boulder, CO, USA) software routine was implemented to manually segment the cartilage from the T~2~maps by one operator (HA). Segmentation was performed on a slice-by-slice basis (spanning all slices), and each region of interest encompassed the entirety of the cartilage tissue. To exclude potential chemical shift artifacts or fluid from the region of interest, the user simultaneously examined the T~2~map and the first echo of the MSME sequence (in neighboring image panels) with synchronized cursor, slice number, and zoom.

T~2~maps were computed on the basis of Equation 1 from the MSME images on a pixel-by-pixel basis by using six echoes (TE = 20 to 70 ms) and three parameter fittings accounting for noise \[[@B22],[@B23]\].

$$S\left( {TE} \right)^{2} = {S_{0}}^{2}e^{- \frac{2*TE}{T_{2}}} + B^{2}$$

In Equation 1, S is the signal intensity at a given echo time (TE), S~0~is the signal intensity at TE = 0 ms, and B is the estimated noise at a given TE. To reduce potential errors resulting from stimulated echoes in a multi-echo Carr-Purcell-Meiboom-Gill sequence \[[@B24],[@B25]\], the first echo (TE = 10 ms) was not included in the T~2~fitting procedure. A noise-corrected algorithm was implemented based on results from a recent study demonstrating increased accuracy and precision of T~2~relaxation time when using a noise-corrected algorithm as compared with the traditional uncorrected exponential fit \[[@B22],[@B23]\]. T~2~quantification was performed with an in-house program created with Matlab (MathWorks, Natick, MA, USA).

Texture analysis
----------------

Texture analysis was performed on a slice-by-slice basis on the cartilage T~2~maps. This method is based on the GLCM as described by Haralick and colleagues \[[@B10]\]. The GLCM determines the frequency that neighboring grey-level values occur in an image. GLCM texture parameters, including contrast, variance, and entropy, were calculated in each cartilage region. The equations for contrast, variance, and entropy are shown below (Equations 2-4), respectively.

$$Entropy = \sum\limits_{i = 1}^{N}\sum\limits_{j = 1}^{N}P\left( {i,j} \right)\left( {- \ln P\left( {i,j} \right)} \right)$$

$$Variance = \sum\limits_{i,j = 0}^{N - 1}P_{i,j}\left( {i - \mu_{i,j}} \right)^{2}$$

Where

$$\mu_{i,j} = \underset{i,j = 0}{\overset{N^{''}1}{\#}}i\left( P_{i,j} \right)$$

$$Contrast = \sum\limits_{i = 1}^{N}\sum\limits_{j = 1}^{N}P\left( {i,j} \right)\left( {i - j} \right)^{2}$$

P represents the probability of the co-occurrence of pixel values i and j in an image. N represents the total number of pixel value co-occurrences in the image. A pixel offset of one pixel was chosen based on the fact that approximately three to four pixels span the cartilage thickness. Analysis was performed by averaging the GLCM parameters across four orientations: 0° (corresponding to the anterior-posterior axis), 45°, 90° (corresponding to the superior-inferior axis), and 135°.

WORMS scoring
-------------

MR images of the right knee were reviewed on picture archiving communication system workstations (Agfa, Ridgefield Park, NJ, USA). A board-certified radiologist (WV) with 7 years of experience and a fourth-year radiology resident (LN) with 3 years of experience read the images independently and graded meniscus, cartilage, and bone marrow lesions. Cartilage and bone marrow lesions were assessed in five compartments (patella, medial femur, medial tibia, lateral femur, and lateral tibia) by using a modified semi-quantitative WORMS \[[@B16],[@B26],[@B27]\], and the highest grade of lesion was recorded for each region. In case of disagreement, a consensus reading was performed with a musculoskeletal radiologist with 22 years of experience (TML). For calibration purposes, the first 20 cases were read simultaneously by the three readers in consensus. Compared with the original WORMS grading system, only six compartments were analyzed as relatively mild lesions were expected. This could have potentially affected the number of grade 4 or grade 6 cartilage lesions as well as grade 3 bone marrow lesions, all of which, however, are rare. Cartilage signal and morphology were scored with an 8-point scale: 0 = normal thickness and signal, 1 = normal thickness but increased signal on T~2~-weighted images, 2.0 = partial-thickness focal defect of less than 1 cm in greatest width, 2.5 = full-thickness focal defect of less than 1 cm in greatest width, 3 = multiple areas of partial-thickness (grade 2.0) defects intermixed with areas of normal thickness or a grade 2.0 defect of wider than 1 cm but less than 75% of the region, 4 = diffuse (at least 75% of the region) partial-thickness loss, 5 = multiple areas of full-thickness loss (grade 2.5) or a grade 2.5 lesion of wider than 1 cm but less than 75% of the region, and 6 = diffuse (at least 75% of the region) full-thickness loss. Meniscal morphology was assessed in six regions by using a modified WORMS: the medial and lateral sides of the anterior, body, and posterior regions; an additional grade was added to the meniscal classification \'intrasubstance degeneration\' to better assess early degenerative disease. The grading scale ranged from 1 to 4: 0 = normal, 1 = intrasubstance abnormalities, 2 = non-displaced tear, 3 = displaced or complex tear, and 4 = complete destruction. Subarticular bone marrow abnormalities were defined as poorly marginated areas of increased signal intensity in the normal subchondral and epiphyseal bone marrow on T~2~-weighted FSE fast-suppressed MR images. A 4-point grading scale was employed to assess the size of the bone marrow abnormalities: 0 = none, 1 = minimal (less than 25% of region), 2 = moderate (25% to 50% of region), and 3 = severe (greater than 50% of region) \[[@B20]\].

Reproducibility
---------------

The reproducibility of WORMS scoring for meniscus, cartilage, and bone marrow tissues was investigated in 15 subjects and read out twice by two radiologists independently. An intraclass correlation coefficient (ICC) was calculated to determine the intra- and inter-reader reproducibility errors \[[@B28]\]. The ICC is mathematically equal to the weighted kappa using quadratic weights \[[@B29],[@B30]\]. The reproducibility of mean T~2~and texture analysis was determined by segmenting the cartilage in five subjects, three times by one operator (HA). The reproducibility error was calculated as the root mean square (RMS) coefficient of variation (CV) of the repeated measurements as described by Glüer and colleagues \[[@B31]\].

Statistical analysis
--------------------

Statistical analysis was performed with STATA 11 software (StataCorp LP, College Station, TX, USA). Descriptive statistics (i.e. mean age, gender, and BMI) were calculated for each group, and differences between groups were assessed by using regression models and a Pearson chi-square test. The association between age and mean T~2~was assessed by using regression models and partial correlations adjusting for group, gender, and BMI.

The primary compartmental predictors of this study were the medial femur, the medial tibia, and the average of all compartments. The medial femur and medial tibia were chosen based on the following rationale: the medial side of the knee is a concentrated region of weight-bearing \[[@B32]\], the medial side of the knee has a higher incidence of OA than the lateral side \[[@B33]\], and meniscal and cartilage lesions are more prevalent on the medial side of the joint \[[@B33]\]. The remaining compartments, including the lateral femur, lateral tibia, and patella, were examined in an exploratory manner. Additionally, three GLCM texture parameters were analyzed (GLCM contrast, GLCM variance, and GLCM entropy) and were regarded as representative parameters from each of the three texture groups (contrast, statistics, and order, respectively). These texture parameters were selected based on of results from previous studies demonstrating their elevation in subjects with OA \[[@B7]-[@B9]\].

Two separate analyses were performed to assess the prevalence of morphologic knee abnormalities in each group: the first analysis defined the prevalence of cartilage (and meniscus) lesions as present for any compartment that had WORMS of greater than 0. The second analysis defined prevalence as present for any compartment that had WORMS of at least 2. The rationale for these chosen cutoff points was to assess subjects with any features of cartilage degeneration (WORMS of greater than 0) and subjects with mild degeneration (WORMS of at least 2). The prevalence of subjects with severe degeneration (WORMS of greater than 4) \[[@B34]\] was scarce (5 subjects overall); thus, this study did not focus on these subjects. The differences in the prevalence of morphologic knee abnormalities between groups were assessed by using logistic regression models (independent variable: group; dependent variable: WORMS prevalence). The prevalence of bone marrow lesions was defined as a BML score greater than 0, and a logistic regression model (described above) was performed to assess the differences in the prevalence of bone marrow lesions between groups.

The differences in T~2~parameters between control group (CG) and incidence group (IG) were assessed by using regression models (independent variables: group; dependent variable: T~2~parameters). To compare the differences in T~2~parameters between groups, the following equation was implemented: (T~2~\_parameter~IG~- T~2~\_parameter~CG~)/(the average standard deviation (SD) of both groups).

The relationship between the prevalence of morphologic abnormalities and cartilage T~2~was investigated by using regression models and partial correlations (independent variables: T~2~parameter and group; dependent variable: \'WORMS max score\'). The WORMS max score is defined as the maximum of the WORMS in all compartments per patient. All models were adjusted for age, gender, and BMI.

Results
=======

The control (n = 53) and incidence (n = 92) groups had no significant differences (*P*\> 0.05) in age or BMI (age~control~= 50.30 ± 3.03 years, age~incidence~= 50.65 ± 2.89 years, *P*= 0.49; BMI~control~= 23.90 ± 2.23 kg/m^2^, BMI~incidence~= 23.78 ± 2.25 kg/m^2^, *P*= 0.78). The incidence group consisted of 50 (54.34%) females, whereas the control group consisted of 36 (67.92%) (*P*\> 0.05) (Table [1](#T1){ref-type="table"}). The incidence group had the following distribution of risk factors: 44 had a previous injury, 19 had previous knee surgery, 19 had a family history of knee replacement, and 17 had Heberden nodes.

###### 

Subject characteristics

  Characteristic                          Incidence cohort   Control cohort   *P*value
  --------------------------------------- ------------------ ---------------- ----------
  Number of subjects                      92                 53               
  Age in years, mean ± SD                 50.65 ± 2.89       50.30 ± 3.03     0.49^a^
  Body mass index in kg/m^2^, mean ± SD   23.78 ± 2.25       23.90 ± 2.23     0.78^a^
  Number of females                       50                 36               0.10^b^
  WOMAC pain score                        0                  0                
  Kellgren-Lawrence score                 0                  0                

^a^Regression model; ^b^Pearson chi-square test. SD, standard deviation; WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.

The reproducibility results for the WORMS grading are listed in Table [2](#T2){ref-type="table"}. The intra-observer reproducibility in all tissues (meniscus, cartilage, and bone marrow) was at least 96%, whereas the inter-observer reproducibility was at least 97%. The reproducibility results for the mean cartilage T~2~and the GLCM texture analysis are listed in Table [3](#T3){ref-type="table"}. The mean T~2~values had RMS CVs ranging from 0.85% in the lateral femur to 2% in the medial tibia. GLCM entropy exhibited the lowest CVs (\<1%), whereas GLCM contrast had CVs of less than 5% in all compartments except for the lateral tibia (8.67%) and medial tibia (11.41%). The CVs for GLCM variance were less than 5%, except for the medial tibia, which had a CV of 7.91%.

###### 

Interclass correlation coefficient \[[@B28]\] of the whole-organ magnetic resonance imaging scores (WORMS) in the meniscus, cartilage, and bone marrow lesions

  Tissue                Reader 1   Reader 2   ICC
  --------------------- ---------- ---------- ------
  Meniscus              0.98       0.96       0.97
  Cartilage             0.98       0.96       0.98
  Bone marrow lesions   0.98       0.97       0.98

The reproducibility of WORMS scores was investigated in 15 subjects and read out twice by two readers independently. ICC, interclass correlation coefficient.

###### 

Reproducibility (coefficient of variation) \[[@B31]\] of T~2~measurements in five subjects segmented three times each by one operator

              Medial   Lateral                   
  ----------- -------- --------- ------- ------- ---------
  Parameter   Femur    Tibia     Femur   Tibia   Patella
  Mean T~2~   0.99     2.08      0.85    1.51    0.86
  Contrast    4.60     11.41     3.61    8.67    4.07
  Entropy     0.47     0.75      0.05    0.03    0.55
  Variance    2.40     7.91      2.12    4.31    3.34

The texture parameters analyzed were at 0 degrees and at 1 pixel offset.

A significant association (*r*= 0.19, *P*= 0.04) was evident between subject age and mean T~2~(adjusting for group, gender, and BMI) in all compartments combined for both the incidence and control groups. The GLCM texture parameters and WORMS max scores were not significantly related to age (*P*\> 0.05) in both groups.

The prevalence of focal knee abnormalities (cartilage lesions, bone marrow lesions, and meniscus lesions) was not significantly (*P*\> 0.05) different between the incidence and control groups (Tables [4](#T4){ref-type="table"}, [5](#T5){ref-type="table"}, [6](#T6){ref-type="table"}). No significant differences between groups were observed when evaluating the overall prevalence of knee abnormalities (Table [4](#T4){ref-type="table"}) or the prevalence of knee abnormalities by compartment (Tables [5](#T5){ref-type="table"} and [6](#T6){ref-type="table"}). The patella had the highest prevalence of cartilage defects (WORMS of greater than 0: 54.5% in the incidence cohort and 57.7% in the control cohort), followed by the lateral tibia (WORMS of greater than 0: 19.3% in the incidence cohort and 22.2% in the control cohort). Also, mensical tears were most abundant in the medial posterior compartment (WORMS of greater than 0: 43.1% in the incidence group and 33.3% in the control group), followed by the medial body (WORMS of greater than 0: 12.5% in the incidence group and 20.0% in the control group).

###### 

Prevalence of focal knee abnormalities in the incidence and control groups

  Lesion                **Control group**^**a**^**(n = 53)**   **Incidence group**^**a**^**(n = 92)**   **Odds ratio**^**b**^   95% confidence interval   
  --------------------- -------------------------------------- ---------------------------------------- ----------------------- ------------------------- ------
  Cartilage                                                                                                                                               
   WORMS \>0            33 (73.3%)                             59 (67.0%)                               0.83                    0.36                      1.88
   WORMS ≥2             19 (42.2%)                             44 (50.0%)                               1.42                    0.66                      3.05
  Bone marrow lesions   19 (42.2%)                             29 (32.9%)                               0.64                    0.29                      1.40
  Meniscus                                                                                                                                                
   WORMS \>0            18 (40.0%)                             42 (47.7%)                               1.52                    0.71                      3.30
   WORMS ≥2             9 (15.5%)                              22 (25.0%)                               2.16                    0.73                      6.35

^a^Eight subjects from the control group and four subjects from the incidence group did not have whole-organ magnetic resonance imaging score (WORMS) readings available. ^b^All *P*values were greater than 0.05 using a logistic regression both when unadjusted and when adjusted for age, body mass index, and gender.

###### 

Prevalence of cartilage abnormalities (cartilage WORMS \>0 and WORMS ≥2) in the incidence and control groups by compartment

  Prevalence of WORMS \>0                                                    
  -------------------------- ------------ ---------- ---------- ------------ ------------
                             Medial       Lateral                            
  Group^a,\ b^               Femur        Tibia      Femur      Tibia        Patella
  Incidence group (n = 92)   11 (12.5%)   4 (4.5%)   8 (9.0%)   17 (19.3%)   48 (54.5%)
  Control group (n = 53)     5 (11.1%)    1 (2.2%)   2 (4.4%)   10 (22.2%)   26 (57.7%)
  Prevalence of WORMS ≥2                                                     
                             Medial       Lateral                            
  Group^a,\ b^               Femur        Tibia      Femur      Tibia        Patella
  Incidence group (n = 92)   10 (11.3%)   3 (3.4%)   6 (6.8%)   10 (11.3%)   25 (28.4%)
  Control group (n = 53)     3 (6.6%)     0 (0.0)%   1 (2.2%)   4 (8.8%)     11 (24.4%)

^a^All *P*values were greater than 0.05 using a logistic regression both when unadjusted and when adjusted for age, body mass index, and gender. ^b^Eight subjects from the control group and four subjects from the incidence group did not have whole-organ magnetic resonance imaging score (WORMS) readings available. Various subjects had lesions in multiple compartments.

###### 

Prevalence of meniscus abnormalities (meniscus WORMS \>0 and WORMS ≥2) in the incidence and control groups by compartment

  Prevalence of WORMS \>0                                                               
  -------------------------- ---------- ------------ ------------ ---------- ---------- ------------
                             Medial     Lateral                                         
  Group^a,\ b^               Anterior   Body         Posterior    Anterior   Body       Posterior
  Incidence group (n = 92)   1 (1.1%)   11 (12.5%)   38 (43.1%)   6 (6.8%)   4 (4.5%)   10 (11.3%)
  Control group (n = 53)     0 (0.0%)   9 (20.0%)    15 (33.3%)   1 (2.2%)   0 (0.0%)   5 (11.1%)
  Prevalence of WORMS ≥2                                                                
                             Medial     Lateral                                         
  Group^a,\ b^               Anterior   Body         Posterior    Anterior   Body       Posterior
  Incidence group (n = 92)   0 (0.0%)   7 (8.3%)     18 (26.4%)   3 (3.5%)   1 (1.1%)   0 (0.0%)
  Control group (n = 53)     0 (0.0%)   5 (12.2%)    5 (14.2%)    1 (2.2%)   0 (0.0%)   1 (2.4%)

^a^All *P*values were greater than 0.05 using a logistic regression both when unadjusted and when adjusted for age, body mass index, and gender. ^b^Eight subjects from the control group and four subjects from the incidence group did not have whole-organ magnetic resonance imaging score (WORMS) readings available. Various subjects had lesions in multiple compartments.

The global mean T~2~, GLCM contrast, and GLCM variance (medial femur, medial tibia, and average of all compartments) were significantly (*P*\< 0.05) elevated in the incidence group compared with the control group. Mean T~2~in the medial femur was greater in the incidence cohort (37.68 ± 2.28 ms) than in the control cohort (36.85 ± 2.16 ms). GLCM entropy (medial femur, medial tibia, and average of all compartments) was elevated in the incidence group but the differences were not significant (*P*\> 0.05). Table [7](#T7){ref-type="table"} summarizes the average values of T~2~parameters in the incidence and control groups. An additional exploratory analysis of remaining compartments demonstrated similar results, but they were not significant. Subjects at risk for OA had elevated mean T~2~, GLCM contrast, and GLCM variance in the lateral femur (*P*\> 0.05), the lateral tibia (*P*\> 0.05), and the patella (*P*\> 0.05). The incidence and control groups had a 0.21 SD difference in mean T~2~, a 0.28 SD difference in entropy, a 0.31 SD difference in variance, and a 0.14 SD difference in entropy (average of all compartments). Figure [1](#F1){ref-type="fig"} illustrates two representative T~2~maps from a control and a subject at risk for OA, respectively. While both subjects do not have cartilage abnormalities (WORMS = 0), the subject from the incidence cohort has greater mean T~2~, GLCM contrast, GLCM variance, and GLCM entropy of cartilage T~2~.

###### 

Average values of T~2~parameters in the incidence and control groups

  Parameter   **Compartment**^**a**^   Incidence group (n = 92)   Control group (n = 53)   *P*value unadjusted   ***P*value adjusted**^**b**^   **Coefficient**^**c**^   95% confidence interval            
  ----------- ------------------------ -------------------------- ------------------------ --------------------- ------------------------------ ------------------------ ------------------------- -------- -------
  T~2~        Mean, ms                 All                        32.65 ± 1.55             32.07 ± 1.38          0.056                          **0.018**                -0.72                     -1.31    -0.12
                                       MF                         37.68 ± 2.28             36.85 ± 2.16          0.042                          **0.003**                -1.18                     -1.94    -0.42
                                       MT                         30.27 ± 1.88             29.51 ± 1.77          0.029                          **0.036**                -0.72                     -1.39    -0.04
  GLCM        Contrast                 All                        248.67 ± 38.39           227.41 ± 35.00        0.005                          **0.003**                -22.81                    -37.48   -8.13
                                       MF                         364.17 ± 68.98           333.37 ± 66.58        0.013                          **0.009**                -32.97                    -57.72   -8.21
                                       MT                         257.30 ± 63.19           226.96 ± 47.83        0.004                          **0.013**                -25.40                    -45.49   -5.48
              Entropy                  All                        6.34 ± 0.16              6.30 ± 0.19           0.142                          0.286                    -0.03                     -0.10    0.03
                                       MF                         6.96 ± 0.17              6.90 ± 0.17           0.055                          0.062                    -0.06                     -0.12    0.003
                                       MT                         6.17 ± 0.28              6.09 ± 0.34           0.050                          0.127                    -0.07                     -0.15    0.02
              Variance                 All                        187.77 ± 26.69           171.74 ± 24.57        0.003                          **0.002**                -16.60                    -27.09   -6.27
                                       MF                         255.64 ± 42.38           233.10 ± 38.60        0.003                          **0.001**                -24.86                    -39.82   -9.91
                                       MT                         183.65 ± 37.88           162.66 ± 32.01        0.001                          **0.005**                -17.89                    -30.31   -5.47

^a^All, average of all compartments: medial femur (MF), medial tibia (MT), lateral femur, lateral tibia, and patella. ^b^*P*value adjusted for age, gender, and body mass index (BMI). ^c^The coefficient is the difference in the T~2~parameter between the incidence and control groups, adjusted for age, gender, and BMI. A coefficient below 0 indicates that the control group has a lower estimated T~2~parameter in comparison with the incidence group. GLCM, grey level co-occurrence matrix.

![**Representative T**~**2**~**maps from a subject from the control cohort (left) and a subject from the incidence cohort (right)**. Cartilage T~2~maps are median-filtered with a 3 × 3 kernal for visualization. Both subjects have no cartilage abnormalities (cartilage whole-organ magnetic resonance imaging scores (WORMS) = 0) and no pain (Western Ontario and McMaster Universities Osteoarthritis Index pain = 0); however, the subject from the incidence cohort has elevated mean T~2~(39.12 versus 33.39 ms), elevated grey level co-occurrence matrix (GLCM) variance (311.63 versus 190.50), elevated GLCM contrast (466.16 versus 266.82), and elevated GLCM entropy (7.17 versus 6.80). Also, the control subject has intrasubstance abnormalities in the medial posterior meniscus (meniscus WORMS = 1). All other meniscus regions had no abnormalities (meniscus WORMS = 0).](ar3469-1){#F1}

Subjects with cartilage abnormalities (cartilage WORMS of greater than 0: n = 92) had significantly (*P*\< 0.05) elevated cartilage T~2~parameters (mean T~2~, GLCM variance, GLCM contrast, and GLCM entropy) than subjects without abnormalities (WORMS = 0: n = 41) in the average of all compartments, in the medial femur, and the patella. The remaining compartments did not demonstrate a significant relationship (*P*\> 0.05). This analysis pooled the incidence and control cohorts and accounted for group in the regression model. Similar trends were observed when subdividing the analysis by group. Note that eight subjects from the control group and four subjects from the incidence group did not have WORMS readings available. Figure [2](#F2){ref-type="fig"} illustrates that the mean T~2~, GLCM contrast, GLCM variance, and GLCM entropy are significantly elevated in subjects with cartilage abnormalities.

![**Comparison of T**~**2**~**and texture parameters in subjects with cartilage abnormalities and those without them**. Subjects with cartilage abnormalities (cartilage whole-organ magnetic resonance imaging scores (WORMS) of greater than 0, n = 92) have elevated mean T~2~, grey level co-occurrence matrix (GLCM) entropy, GLCM contrast, and GLCM variance in comparison with subjects without abnormalities (cartilage WORMS = 0, n = 41). Values are averaged among all compartments.](ar3469-2){#F2}

A positive relationship between cartilage WORMS max score and T~2~parameters (mean cartilage T~2~(partial correlation adjusting for age, gender, and BMI) *r*= 0.31, *P*= 0.0007), GLCM variance (*r*= 0.18, *P*= 0.04), GLCM contrast (*r*= 0.17, *P*= 0.03), and GLCM entropy (*r*= 0.31, *P*= 0.09) was demonstrated in the medial femur and across both the control and incidence groups. The remaining compartments demonstrated similar trends but the correlations were not significant (*P*\> 0.05).

Discussion
==========

This study evaluated the differences in knee morphology and biochemical composition in the incidence and control groups of the OAI. While there was no significant difference in the prevalence of knee abnormalities (cartilage lesions, bone marrow lesions, and meniscus lesions) between the incidence and control groups, T~2~parameters (mean T~2~, GLCM contrast, and GLCM variance) were significantly elevated in the incidence group. These results demonstrate that subjects at risk for OA may experience early breakdown of the cartilage extracellular matrix (ECM), such as changes to the collagen structure and increased mobility of water, prior to cartilage degeneration. It is interesting that both subject groups had neither pain (WOMAC pain = 0) nor radiographic evidence (KL score of 0 in the tibiofemoral joint) of OA at baseline yet had varying biochemical compositions. These results suggest that T~2~mapping may be useful in detecting early arthritic biochemical cartilage changes that precede morphologic degeneration in OA.

While radiography did not demonstrate joint space narrowing or osteophytes in either subject group, MRI detected cartilage and meniscus defects in both groups. The patellar cartilage had the highest prevalence of abnormalities compared with the other compartments, and this corroborates previous studies in athletes \[[@B35]\], candidates for cartilage repair surgery \[[@B36]\], and controls and subjects who developed frequent knee symptoms over 15 months \[[@B34]\]. The posterior horn of the medial meniscus had the highest prevalence of meniscus degeneration, and this has been previously reported \[[@B37]-[@B39]\]. Previous studies have demonstrated discordant findings between radiographic and arthroscopic joint damage: subjects with normal radiographic KL scores often demonstrated advanced OA when arthroscopy was used \[[@B14]\]. Thus, soft tissue degeneration in the knee may not closely correspond with joint space narrowing \[[@B14],[@B15]\], and radiography may not be optimal for assessing early-stage arthritic joint degeneration.

Interestingly, the prevalence of cartilage and meniscus morphologic abnormalities was similar between controls and subjects at risk for OA. One might expect that subjects at risk for OA may have an increased number of morphologic abnormalities; however, this was not the case in this study. Similar results were reported in a study by Crema and colleagues \[[@B39]\], who demonstrated that the prevalence of meniscal abnormalities was similar between patients with OA (frequent knee symptoms and KL score of 2 to 3) and controls. In addition, Javaid and colleagues \[[@B34]\] reported that the prevalence of cartilage lesions (any feature damage, whole knee) was similar between OA subjects (KL score of 0 at baseline) who developed frequent knee symptoms over 15 months (80.6%) and controls (67.2%); however, severe cartilage lesions were significantly more prevalent in subjects with OA (22.2% in subjects with OA and 8.6% in controls). The results of these studies suggest that control subjects have a similar prevalence of morphologic abnormalities as those at risk for OA and those with mild/moderate OA; thus, the use of morphologic grading to discriminate between subjects with early OA and controls may be challenging.

While the prevalence of morphologic abnormalities was similar between groups, the mean T~2~significantly differed, indicating that subjects at risk for OA have altered cartilage biochemistry. Cartilage T~2~relaxation time is sensitive to the mobility of water in cartilage tissue \[[@B40]\], water content \[[@B41]\], and collagen fiber orientation \[[@B42]\]; changes to these elements of the ECM characterize the initial stages of early OA, eventually leading to gross joint degeneration as detected by morphologic MRI. The elevation of cartilage T~2~suggests that early cartilage biochemical changes may be of primary interest when assessing subjects at risk for OA.

While elevated mean T~2~values are associated with OA, the heterogeneous nature of cartilage tissue is also an important consideration when quantifying cartilage tissue integrity. Nissi and colleagues \[[@B43]\] reported that healthy bovine cartilage samples showed a laminar appearance while spontaneously degenerated bovine cartilage tissue did not, demonstrating changes in the distribution of cartilage ECM components with degeneration. In addition, previous studies have shown varying T~2~relaxation times from the cartilage-bone interface to the joint surface \[[@B24],[@B40],[@B44]-[@B47]\] and varying spatial patterns of T~2~values in osteoarthritic cartilage \[[@B48]\]. Therefore, quantifying only mean values of cartilage T~2~may mask important information regarding the spatial changes occurring in the ECM during degeneration.

The results of this study demonstrated that subjects at risk for OA have localized variations in their cartilage composition, as evidenced by their elevated GLCM contrast, GLCM entropy, and GLCM variance. Specifically, GLCM contrast is a measure of the differences in neighboring pixel values; high contrast signifies that many pixels with different values are neighboring. GLCM entropy is a measure of disorder in an image; high entropy signifies that the probability of pixel co-occurrence is uniform throughout an image. GLCM variance is a measure of the distribution of pixels about the mean; high variance signifies a high dispersion of co-occurrences of relaxation times. Previous studies have demonstrated differences in the spatial distribution of cartilage relaxation times in subjects with OA and those without OA. For example, Carballido-Gamio and colleagues \[[@B9]\] demonstrated elevated GLCM contrast and GLCM entropy of T1 relaxation time in rotating frame (T~1ρ~) and T~2~in subjects with mild OA as compared with controls; Li and colleagues \[[@B8]\] demonstrated elevated GLCM contrast and entropy of patellar cartilage T~1ρ~in patients with OA compared with controls; and Blumenkrantz and colleagues \[[@B7]\] demonstrated elevated GLCM entropy of cartilage T~2~in patients with OA as compared with controls. Additionally, Burstein and colleagues \[[@B49]\] illustrated a loss of normal spatial dependency of cartilage T~2~relaxation times in a patient with anterior knee pain and chronic chondral injury. The authors suggested that areas of high T~2~-weighted signal (frequently associated with cartilage injury) are often adjacent to areas with low T~2~. Such degenerative changes in cartilage tissue due to disease or injury are reflected by the spatial distribution of T~2~values and can be quantified by GLCM texture analysis.

This study demonstrated that cartilage abnormalities were associated with elevated and more heterogeneous cartilage T~2~values, corroborating previous research: Blumenkrantz and colleagues \[[@B50]\] found an association between cartilage T~2~and cartilage thickness, Mosher and colleagues \[[@B51]\] reported changes in cartilage T~2~and cartilage thickness after running, Stahl and colleagues \[[@B52]\] reported associations between cartilage T~2~and cartilage volume and thickness, and Stehling and colleagues \[[@B20]\] demonstrated a relationship between patellar cartilage T~2~and cartilage morphology (WORMS). These results highlight the complex interrelationship between biochemical cartilage changes and consequent morphologic cartilage loss and suggest that biochemical cartilage composition as measured by T~2~may be associated with cartilage loss.

Several limitations are pertinent to this study: it may have been useful to subdivide the cartilage into weight-bearing and non-weight-bearing regions. To minimize errors due to multiple comparisons, this type of segmentation was not performed. Furthermore, other techniques such as dGEMRIC (delayed gadolinium-enhanced MRI of cartilage) or T~1ρ~may have been useful in investigating the ECM during OA progression; however, this study did not employ these methods, as the required MRI sequences were not acquired in the OAI protocol.

Because the feasibility of GLCM texture analysis by using the OAI dataset was demonstrated by Carballido-Gamio and colleagues \[[@B53]\], their study provided the foundation for the present study. The present study evaluated a larger subject cohort (145 versus 13 subjects), examined distinct subject groups (we examined subjects at risk for OA and healthy controls while Carballido-Gamio and colleagues \[[@B53]\] examined subjects with symptomatic and radiographic OA), and assessed joint morphology in addition to cartilage T~2~. Thus, the present study is unique in assessing the spatial distribution of cartilage T~2~values by using GLCM texture analysis in a large cohort at risk for OA.

Conclusions
===========

This study demonstrated that subjects at risk for OA have both higher and more heterogeneous T~2~values than controls and that subjects with cartilage abnormalities have elevated cartilage T~2~parameters compared with subjects without abnormalities. While joint morphology was similar in both groups, cartilage T~2~parameters showed significant differences, suggesting that T~2~relaxation time may be a valuable early marker for OA.
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